SI-BONE Q2 2024 GAAP EPS $(0.22) Beats $(0.28) Estimate, Sales $39.969M Beat $38.319M Estimate
Portfolio Pulse from Benzinga Newsdesk
SI-BONE (NASDAQ:SIBN) reported Q2 2024 GAAP EPS of $(0.22), beating the estimate of $(0.28) and showing a 26.67% improvement from last year. Sales were $39.969M, surpassing the $38.319M estimate and marking a 20.01% increase from the previous year.
August 05, 2024 | 8:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
SI-BONE reported better-than-expected Q2 2024 results with a GAAP EPS of $(0.22) beating the $(0.28) estimate and sales of $39.969M surpassing the $38.319M estimate. This indicates strong operational performance and growth.
The better-than-expected earnings and sales figures indicate strong operational performance and growth, which is likely to positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100